Tivumecirnon | Interleukin Related interleukin-related.com

Product Name :
Tivumecirnon

Search keywords :
Tivumecirnon

drugId :
null

Target Vo:
C-C chemokine receptor type 4

Target Vo Short Name :
CCR4

Moa_Name:
C-C chemokine receptor type 4 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Rapt Therapeutics Inc

Active Company_Name :
Hanmi Pharmaceutical Co Ltd

Active Indication_Name:
Stomach Neoplasms

In Active Indication_Name:
Melanoma

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HDAC4 Antibody (YA741)
p53 (acetyl K370)Antibody
Cytokeratin 20 Antibody: Cytokeratin 20 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 20 monoclonal antibody. Cytokeratin 20 Antibody can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human, rat background without labeling.

Author: Interleukin Related

Related Posts